Early puberty and risk for type 2 diabetes in men.
Childhood BMI
Cohort
Endocrinology
Epidemiology
National registers
Paediatrics
Puberty
School health records
Type 2 diabetes
Journal
Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
12
12
2019
accepted:
10
02
2020
pubmed:
24
3
2020
medline:
30
9
2021
entrez:
24
3
2020
Statut:
ppublish
Résumé
The association between pubertal timing and type 2 diabetes, independent of prepubertal BMI, is not fully understood. The aim of the present study was to evaluate the association between pubertal timing and risk of adult type 2 diabetes, independent of prepubertal BMI, in Swedish men. We included 30,697 men who had data for BMI at age 8 and 20 years and age at Peak Height Velocity (PHV), an objective assessment of pubertal timing, available from the BMI Epidemiology Study Gothenburg (BEST Gothenburg), Sweden. Information on type 2 diabetes (n = 1851) was retrieved from the Swedish National Patient Register. HRs and 95% CIs were estimated by Cox regression analysis. We observed violations of the assumption of proportional hazards for the association between age at PHV and the risk of type 2 diabetes and therefore split the follow-up period at the median age of type 2 diabetes diagnosis (57.2 years of age) to define early (≤57.2 years) and late (>57.2 years) type 2 diabetes diagnosis. Age at PHV was inversely associated with both early (HR 1.28 per year decrease in age at PHV, 95% CI 1.21, 1.36) and late (HR 1.13, 95% CI 1.06, 1.19) type 2 diabetes. After adjustment for childhood BMI, the associations between age at PHV and both early (HR 1.24, 95% CI 1.17, 1.31) and late (HR 1.11, 95% CI 1.05, 1.17) type 2 diabetes were similar. Moreover, early age at PHV predicted insulin treatment of type 2 diabetes (OR 1.25 per year decrease in age at PHV, 95% CI 1.17, 1.33). Assuming a higher risk among those with an age at PHV below the median, the population attributable factor indicates that 15% fewer of the diagnosed individuals would have developed type 2 diabetes had they not reached puberty early. These findings indicate that early puberty may be a novel independent risk factor for type 2 diabetes.
Identifiants
pubmed: 32201902
doi: 10.1007/s00125-020-05121-8
pii: 10.1007/s00125-020-05121-8
pmc: PMC7228987
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1141-1150Subventions
Organisme : Hjärt-Lungfonden
ID : 20190624
Pays : International
Organisme : Vetenskapsrådet
ID : 2018-02597
Pays : International
Organisme : Lars Erik Lundbergs Stiftelse för Forskning och Utbildning
ID : 2017-0081
Pays : International
Organisme : Knut och Alice Wallenbergs Stiftelse
ID : KAW2015.0317
Pays : International
Organisme : NovoNordisk Foundation
ID : NNF180C0033898
Pays : International
Organisme : Grants from the Swedish state under the agreement between the Swedish government and county councils (ALF-agreement)
ID : ALFGBG-723791
Pays : International
Organisme : Torsten Söderbergs Stiftelse
ID : M65/15
Pays : International
Références
Obesity (Silver Spring). 2017 May;25(5):965-971
pubmed: 28345789
N Engl J Med. 2018 Apr 05;378(14):1302-1312
pubmed: 29617589
J Clin Endocrinol Metab. 2019 May 1;104(5):1823-1832
pubmed: 30517677
Sci Rep. 2015 Jun 18;5:11208
pubmed: 26084728
BMC Med Res Methodol. 2011 Jan 17;11:7
pubmed: 21241500
Diabetes Care. 2013 Nov;36(11):3526-34
pubmed: 24159179
J Epidemiol Community Health. 2006 Nov;60(11):993-7
pubmed: 17053289
N Engl J Med. 2001 May 3;344(18):1343-50
pubmed: 11333990
BMJ. 2018 Feb 22;360:k757
pubmed: 29472187
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Obes Rev. 2017 Nov;18(11):1272-1288
pubmed: 28872224
Vital Health Stat 11. 2002 May;(246):1-190
pubmed: 12043359
Br J Cancer. 2010 Nov 23;103(11):1760-4
pubmed: 21045834
J Obes. 2011;2011:180729
pubmed: 21773002
N Engl J Med. 1982 Apr 29;306(17):1033-5
pubmed: 7062994
Pediatrics. 2008 Feb;121 Suppl 3:S208-17
pubmed: 18245513
Lancet Diabetes Endocrinol. 2016 Dec;4(12):1017-1024
pubmed: 27815089
J Pediatr. 2015 Aug;167(2):344-52.e1
pubmed: 25962931
Am J Clin Nutr. 2018 Dec 1;108(6):1259-1263
pubmed: 30321255
J Pediatr Endocrinol Metab. 2009 Apr;22(4):291-9
pubmed: 19554802
JAMA Pediatr. 2019 Jul 22;:
pubmed: 31329245
Stat Med. 1987 Mar;6(2):185-92
pubmed: 3589247
Br J Cancer. 1999 Apr;79(11-12):1907-11
pubmed: 10206312
Int J Obes (Lond). 2013 Aug;37(8):1036-43
pubmed: 23164700
Diabetes Care. 2012 Apr;35(4):850-6
pubmed: 22338106
Diabetes. 2006 Nov;55(11):3047-52
pubmed: 17065341
Diabetologia. 2008 May;51(5):781-6
pubmed: 18320165
Endocr Rev. 2003 Oct;24(5):668-93
pubmed: 14570750
Diabet Med. 2012 May;29(5):600-3
pubmed: 21999522
Pediatrics. 2002 Oct;110(4):e43
pubmed: 12359816
Int J Obes (Lond). 2006 Jan;30(1):14-22
pubmed: 16344844
J Clin Endocrinol Metab. 2012 Aug;97(8):2844-52
pubmed: 22654120